Neurovirulence
Found 4 free book(s)CONTENTSOFSUPPLEMENT9 - EDQM
www.edqm.euEUROPEAN PHARMACOPOEIA 9.4 Contents of Supplement 9.4 The following text is deleted as of1 July 2017. GENERAL CHAPTERS 2.6.19. Test for neurovirulence of poliomyelitis vaccine (oral) The following text is deleted as of1 April 2017. GENERAL CHAPTERS
Transgenic mice as an alternative to monkeys for ...
www.who.intTransgenic mice as an alternative to monkeys for neurovirulence testing of live oral poliovirus vaccine: validation by a WHO collaborative study
Annex 2 - WHO
www.who.intAnnex 2 51 Introduction WHO Requirements for oral poliomyelitis vaccine (OPV) were first formulated in 1962 (1), and revised in 1965 (2), and then again in 1971 (3), when an appendix describing the production of OPV in human diploid cells was added.
EUROPEAN PHARMACOPOEIA 9.5 CONTENTSOFSUPPLEMENT9 - EDQM
www.edqm.euEUROPEAN PHARMACOPOEIA 9.5 Contents of Supplement 9.5 CONTENTSOFSUPPLEMENT9.5 A vertical line in the margin indicates where part of a text has been revised or corrected. A horizontal line in the margin indicates